Dr. Dezube is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Avenue
Beth Israel Hospital
Boston, MA 02215Phone+1 617-632-9258
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1986 - 1991
Tufts Medical CenterResidency, Internal Medicine, 1983 - 1986
Tufts University School of MedicineClass of 1983
Certifications & Licensure
MA State Medical License 1985 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
Publications & Presentations
PubMed
- 12 citationsIOLite: phase 1b trial of doublet/triplet combinations of dostarlimab with niraparib, carboplatin-paclitaxel, with or without bevacizumab in patients with advanced can...Timothy A Yap, Alberto Bessudo, Erika Hamilton, Jasgit Sachdev, Manish R Patel
Journal for Immunotherapy of Cancer. 2022-03-01 - 7 citationsAuthor Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer.Anniina Färkkilä, Doga Gulhan, Julia Casado, Connor A. Jacobson, Huy V. Nguyen
Nature Communications. 2020-05-18 - 193 citationsImmunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer.Anniina Färkkilä, Doga Gulhan, Julia Casado, Connor A. Jacobson, Huy V. Nguyen
Nature Communications. 2020-03-19
Other
- Pulmonary involvement in AIDS-related Kaposi sarcomaDezube BJ, King TE
http://www.uptodate.com/contents/pulmonary-involvement-in-aids-related-kaposi-sarcoma
UpToDate, Wolters Kluwer Health - 2012-11-02 - Psychogenic purpura (Gardner-Diamond syndrome)Dezube BJ, Geisler BP
http://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome
UpToDate, Wolters Kluwer Health - 2012-02-28
Press Mentions
Clinical Trial Underscores Promise of Immunotherapy, in Combination with Second Drug, for Ovarian CancerJuly 13th, 2019
Grant Support
- Novel Immunomodulator A-007 Of Human Pappilomavirus Infection: A Phase II StudyNational Center For Research Resources2007
- Novel Immunomodulator A-007 Of Human Papillomavirus Infection: A Phase II StudyNational Center For Research Resources2006
- Beth Israel Deaconess Medical CenterNational Cancer Institute2006
- Phase I Trial Of Pehrg214 In Patients With HIV InfectionNational Center For Research Resources2004–2005
- Oral Biology Of The Ks-Associated Herpes VirusNational Center For Research Resources2004–2005
- Phase I Trial Of Col 3 In HIV Related Kaposi'S SarcomaNational Center For Research Resources2000–2002
- Trial Of Hnm01 In Patients With HIV InfectionNational Center For Research Resources1999–2002
- Potential Interactions Between Paclitaxel &Protease Inhibitors In KSNational Center For Research Resources1999–2002
- Interaction Between S 1153 &Nelfinavir &Indinavir In HIVNational Center For Research Resources1999–2002
- Phase I Trial Of S-1153 In Patients With HIV InfectionNational Center For Research Resources1997–2000
- Phase I Trial Of FP-21399 In Patients With HIV InfectionNational Center For Research Resources1996–1999
- Phase I Study Of TNP-470 In The Treatment Of AIDS Associated Kaposi'S SarcomaNational Center For Research Resources1997
- Phase I Study Of TNP-470 In The Treatment Of Aids-Associated Kaposi'S SarcomaNational Center For Research Resources1995–1996
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
